Shilpa Medicare

Pharma stocks have been attracting FIIs. Here are three stocks where FIIs have hiked stake in the March 2026 quarter.

The domestic equity markets are closed on Good Friday. On April 2, Nifty 50 rose 0.15% and Sensex 0.25% despite ongoing market challenges due to the Iran conflict and rising crude prices. India's manufacturing sector slowed, raising concerns over growth and inflation.

Nine stocks are set to undergo stock splits or issue bonus shares in the upcoming month of October, following recent corporate announcements.

Here’s a quick look at stocks likely to be in focus in today's trade.

Sumeet Bagadia recommends five breakout stocks to buy today: Gujarat Apollo Industries, Vimta Labs, Skipper Ltd (India), Indian Metals and Ferro Alloys, and Shilpa Medicare.

India's pharmaceutical sector faced a 6% decline in the Nifty Pharma index in 2025, while the Nifty 50 index rose 8%. Major firms experienced significant losses, though some companies like Laurus Labs and Abbott India saw gains amid investor concerns over tariffs and macroeconomic issues.

Amid market fluctuations, microcap stocks such as Shilpa Medicare and Va Tech Wabag achieved significant gains. The Nifty Microcap 250 index outperformed the Nifty 50, rising 2.33% over the past week, with Dishman Carbogen Amics, Reliance Infra emerging as top gainers.

Q4 results on May 26: GIC, Vadilal Industries, Aurobindo Pharma, Sumitomo Chemical, Nazara Technologies, and Blue Dart are among 205 companies to release their earnings report today.